<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459970</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Evaluation of a Commercial Rapid Molecular Point-of-Care Assay for Differential Diagnosis Between SARS-CoV-2 and Flu A/B Infections in a Pediatric Setting.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1638</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16101638</ELocationID><Abstract><AbstractText>Given the ongoing COVID-19 pandemic, there is a need to identify SARS-CoV-2 and to differentiate it from other respiratory viral infections, especially influenza A and B, in various critical settings. Since their introduction, the use of rapid antigen tests has spread worldwide, but there is variability in their diagnostic accuracy. In the present study, we evaluated the clinical performance of the ID NOW™ COVID-19 2.0, a molecular point-of-care test (POCT) based on enzymatic isothermal amplification for the differential diagnosis of SARS-CoV-2 and influenza A/B in a pediatric emergency setting. A cohort of pediatric patients admitted between December 2022 and February 2023 were simultaneously tested with the POCT and standard laboratory molecular assay. Our findings showed high negative agreement of the POCT assay across the different age groups for SARS-CoV-2, influenza A, and influenza B (more than 98.0%), while its positive agreement varied significantly for the abovementioned viral species from 50.0% to 100%. These results highlight the potential of the ID NOW™ COVID-19 2.0 POCT assay as a reliable and rapid tool for excluding SARS-CoV-2 and influenza A/B infections in symptomatic pediatric patients, although its variable positive agreement suggests a need for confirmatory RT-qPCR testing in certain clinical and epidemiological settings in order to ensure accurate diagnosis and appropriate patient management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bottino</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6337-5729</Identifier><AffiliationInfo><Affiliation>Microbiology and Virology Laboratory, University Hospital "SS Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Massarino</LastName><ForeName>Costanza</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0002-2744-5301</Identifier><AffiliationInfo><Affiliation>Research and Innovation Department (DAIRI), University Hospital "SS. Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leli</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8689-7028</Identifier><AffiliationInfo><Affiliation>Microbiology and Virology Laboratory, University Hospital "SS Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scomparin</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Microbiology and Virology Laboratory, University Hospital "SS Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bara</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Microbiology and Virology Laboratory, University Hospital "SS Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gotta</LastName><ForeName>Franca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Microbiology and Virology Laboratory, University Hospital "SS Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cornaglia</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Microbiology and Virology Laboratory, University Hospital "SS Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felici</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Pediatric and Pediatric Emergency Unit, University Hospital "SS. Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentile</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric and Pediatric Emergency Unit, University Hospital "SS. Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranzan</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Science and Technological Innovation (DISIT), University of Eastern Piedmont, Viale Teresa Michel 12 11, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francese</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5999-6111</Identifier><AffiliationInfo><Affiliation>Research and Innovation Department (DAIRI), University Hospital "SS. Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ugo</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Research and Innovation Department (DAIRI), University Hospital "SS. Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penpa</LastName><ForeName>Serena</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-4274-8792</Identifier><AffiliationInfo><Affiliation>Research and Innovation Department (DAIRI), University Hospital "SS. Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roveta</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2484-0963</Identifier><AffiliationInfo><Affiliation>Research and Innovation Department (DAIRI), University Hospital "SS. Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maconi</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1904-7277</Identifier><AffiliationInfo><Affiliation>Research and Innovation Department (DAIRI), University Hospital "SS. Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocchetti</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Microbiology and Virology Laboratory, University Hospital "SS Antonio e Biagio e C. Arrigo", Via Venezia 16, 15121 Alessandria, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023362">Evaluation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067716" MajorTopicYN="Y">Point-of-Care Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="Y">Influenza A virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009981" MajorTopicYN="Y">Influenza B virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025202" MajorTopicYN="N">Molecular Diagnostic Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021141" MajorTopicYN="N">Nucleic Acid Amplification Techniques</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019095" MajorTopicYN="N">Point-of-Care Systems</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ID NOW</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">influenza A/B</Keyword><Keyword MajorTopicYN="N">pediatric respiratory infections</Keyword><Keyword MajorTopicYN="N">point-of-care testing</Keyword><Keyword MajorTopicYN="N">rapid molecular assay</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459970</ArticleId><ArticleId IdType="pmc">PMC11512318</ArticleId><ArticleId IdType="doi">10.3390/v16101638</ArticleId><ArticleId IdType="pii">v16101638</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Perin J., Mulick A., Yeung D., Villavicencio F., Lopez G., Strong K.L., Prieto-Merino D., Cousens S., Black R.E., Liu L. Global, regional, and national causes of under-5 mortality in 2000-19: An updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc. Health. 2022;6:106–115. doi: 10.1016/S2352-4642(21)00311-4. Erratum in Lancet Child Adolesc. Health 2022, 6, e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00311-4</ArticleId><ArticleId IdType="pmc">PMC8786667</ArticleId><ArticleId IdType="pubmed">34800370</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Health Estimates: Leading Causes of Death [Internet]. World Health Organization. 2020.  [(accessed on 11 April 2024)].  Available online:  https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death.</Citation></Reference><Reference><Citation>da Silva S.J.R., do Nascimento J.C.F., Germano Mendes R.P., Guarines K.M., Targino Alves da Silva C., da Silva P.G., de Magalhães J.J.F., Vigar J.R.J., Silva-Júnior A., Kohl A., et al. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect. Dis. 2022;8:1758–1814. doi: 10.1021/acsinfecdis.2c00204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.2c00204</ArticleId><ArticleId IdType="pmc">PMC9380879</ArticleId><ArticleId IdType="pubmed">35940589</ArticleId></ArticleIdList></Reference><Reference><Citation>Why Is COVID-19 Data Being Presented as Weekly Statistics? [Internet]. World Health Organization.  [(accessed on 11 April 2024)].  Available online:  https://data.who.int/dashboards/covid19/cases?n=c.</Citation></Reference><Reference><Citation>Javanian M., Barary M., Ghebrehewet S., Koppolu V., Vasigala V., Ebrahimpour S. A brief review of influenza virus infection. J. Med. Virol. 2021;93:4638–4646. doi: 10.1002/jmv.26990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26990</ArticleId><ArticleId IdType="pubmed">33792930</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao W., Li X., Goraya M.U., Wang S., Chen J.L. Evolution of Influenza A Virus by Mutation and Re-Assortment. Int. J. Mol. Sci. 2017;18:1650. doi: 10.3390/ijms18081650.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18081650</ArticleId><ArticleId IdType="pmc">PMC5578040</ArticleId><ArticleId IdType="pubmed">28783091</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhanasekaran V., Sullivan S., Edwards K.M., Xie R., Khvorov A., Valkenburg S.A., Cowling B.J., Barr I.G. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nat. Commun. 2022;13:1721. doi: 10.1038/s41467-022-29402-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29402-5</ArticleId><ArticleId IdType="pmc">PMC8971476</ArticleId><ArticleId IdType="pubmed">35361789</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubale J.T., Frutos A.M., Balmaseda A., Cerpas C., Saborio S., Ojeda S., Barilla C., Sanchez N., Vasquez G., Moreira H., et al. High Co-circulation of Influenza and Severe Acute Respiratory Syndrome Coronavirus 2. Open Forum Infect. Dis. 2022;9:ofac642. doi: 10.1093/ofid/ofac642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac642</ArticleId><ArticleId IdType="pmc">PMC9745763</ArticleId><ArticleId IdType="pubmed">36519125</ArticleId></ArticleIdList></Reference><Reference><Citation>Widyasari K., Kim S., Kim S., Lim C.S. Performance Evaluation of STANDARD Q COVID/FLU Ag Combo for Detection of SARS-CoV-2 and Influenza A/B. Diagnostics. 2022;13:32. doi: 10.3390/diagnostics13010032.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13010032</ArticleId><ArticleId IdType="pmc">PMC9818676</ArticleId><ArticleId IdType="pubmed">36611324</ArticleId></ArticleIdList></Reference><Reference><Citation>Siordia J.A., Jr. Epidemiology and clinical features of COVID-19: A review of current literature. J. Clin. Virol. 2020;127:104357. doi: 10.1016/j.jcv.2020.104357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104357</ArticleId><ArticleId IdType="pmc">PMC7195311</ArticleId><ArticleId IdType="pubmed">32305884</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Liu M., Wang Z., Li S., Deng Y., He N. Point-of-care diagnostics for infectious diseases: From methods to devices. Nano Today. 2021;37:101092. doi: 10.1016/j.nantod.2021.101092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nantod.2021.101092</ArticleId><ArticleId IdType="pmc">PMC7864790</ArticleId><ArticleId IdType="pubmed">33584847</ArticleId></ArticleIdList></Reference><Reference><Citation>Leli C., Ferrara L., Bottino P., Bara C., Megna I., Penpa S., Felici E., Maconi A., Rocchetti A. Application of a SARS-CoV-2 Antigen Rapid Immunoassay Based on Active Microfluidic Technology in a Setting of Children and Young Adults. Viruses. 2023;16:41. doi: 10.3390/v16010041.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16010041</ArticleId><ArticleId IdType="pmc">PMC10818591</ArticleId><ArticleId IdType="pubmed">38257741</ArticleId></ArticleIdList></Reference><Reference><Citation>Iliescu F.S., Ionescu A.M., Gogianu L., Simion M., Dediu V., Chifiriuc M.C., Pircalabioru G.G., Iliescu C. Point-of-Care Testing-The Key in the Battle against SARS-CoV-2 Pandemic. Micromachines. 2021;12:1464. doi: 10.3390/mi12121464.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/mi12121464</ArticleId><ArticleId IdType="pmc">PMC8708595</ArticleId><ArticleId IdType="pubmed">34945314</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang T., Cha J.H., Kim J., Kim K.J., Nam M., Nam M.H., Kim D.W., Cho Y., Lee C.K., Yun S.G. Evaluation of Multiplex Rapid Antigen Test for the Detection of SARS-CoV-2 and Influenza A/B in Respiratory Samples. Clin. Lab. 2024;70 doi: 10.7754/Clin.Lab.2023.231003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7754/Clin.Lab.2023.231003</ArticleId><ArticleId IdType="pubmed">38469788</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Qiao L., Yao J., Yu N., Mu X., Huang S., Hu B., Li W., Qiu F., Zeng F., et al. Epidemiological and clinical characteristics of respiratory viruses in 4403 pediatric patients from multiple hospitals in Guangdong, China. BMC Pediatr. 2021;21:284. doi: 10.1186/s12887-021-02759-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-021-02759-0</ArticleId><ArticleId IdType="pmc">PMC8212487</ArticleId><ArticleId IdType="pubmed">34140022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabai J., Ihling C.M., Manuel B., Rehbein R.M., Schnee S.V., Hoos J., Pfeil J., Grulich-Henn J., Schnitzler P. Viral Etiology and Clinical Characteristics of Acute Respiratory Tract Infections in Hospitalized Children in Southern Germany (2014–2018) Open Forum Infect. Dis. 2023;10:ofad110. doi: 10.1093/ofid/ofad110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad110</ArticleId><ArticleId IdType="pmc">PMC10034757</ArticleId><ArticleId IdType="pubmed">36968956</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazra A., Gogtay N. Biostatistics Series Module 7: The Statistics of Diagnostic Tests. Indian J. Dermatol. 2017;62:18–24. doi: 10.4103/0019-5154.198047.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0019-5154.198047</ArticleId><ArticleId IdType="pmc">PMC5286748</ArticleId><ArticleId IdType="pubmed">28216720</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa H.H., Carroll K.C., Hicken R., Berry G.J., Manji R., Smith E., Rakeman J.L., Fowler R.C., Leelawong M., Butler-Wu S.M., et al. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test. J. Clin. Microbiol. 2021;59:e02955-20. doi: 10.1128/JCM.02955-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02955-20</ArticleId><ArticleId IdType="pmc">PMC8106732</ArticleId><ArticleId IdType="pubmed">33298613</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira W., Pallás-Tamarit Y., Juste-Dolz A., Sena-Torralba A., Gozalbo-Rovira R., Rodríguez-Díaz J., Navarro D., Carrascosa J., Gimenez-Romero D., Maquieira Á., Morais S. An all-in-one point-of-care testing device for multiplexed detection of respiratory infections. Biosens. Bioelectron. 2022;213:114454. doi: 10.1016/j.bios.2022.114454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2022.114454</ArticleId><ArticleId IdType="pmc">PMC9176175</ArticleId><ArticleId IdType="pubmed">35696866</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottino P., Pizzo V., Castaldo S., Scomparin E., Bara C., Cerrato M., Sisinni S., Penpa S., Roveta A., Gerbino M., et al. Clinical Evaluation and Comparison of Two Microfluidic Antigenic Assays for Detection of SARS-CoV-2 Virus. Microorganisms. 2023;11:2709. doi: 10.3390/microorganisms11112709.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11112709</ArticleId><ArticleId IdType="pmc">PMC10673207</ArticleId><ArticleId IdType="pubmed">38004721</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinnes J., Sharma P., Berhane S., van Wyk S.S., Nyaaba N., Domen J., Taylor M., Cunningham J., Davenport C., Cochrane COVID-19 Diagnostic Test Accuracy Group et al. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst. Rev. 2022;7:CD013705. doi: 10.1002/14651858.CD013705.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013705.pub3</ArticleId><ArticleId IdType="pmc">PMC9305720</ArticleId><ArticleId IdType="pubmed">35866452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim H.J., Lee J.Y., Baek Y.H., Park M.Y., Youm D.J., Kim I., Kim M.J., Choi J., Sohn Y.H., Park J.E., et al. Evaluation of Multiplex Rapid Antigen Tests for the Simultaneous Detection of SARS-CoV-2 and Influenza A/B Viruses. Biomedicines. 2023;11:3267. doi: 10.3390/biomedicines11123267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11123267</ArticleId><ArticleId IdType="pmc">PMC10741453</ArticleId><ArticleId IdType="pubmed">38137488</ArticleId></ArticleIdList></Reference><Reference><Citation>Alp A. Hasta Başı Moleküler Testlerde Son Gelişmeler [Recent Advances in Molecular Point of Care Tests] Mikrobiyol. Bul. 2022;56:580–591. doi: 10.5578/mb.20229717.</Citation><ArticleIdList><ArticleId IdType="doi">10.5578/mb.20229717</ArticleId><ArticleId IdType="pubmed">35960248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubina R., Dziedzic A. Molecular and Serological Tests for COVID-19 a Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics. Diagnostics. 2020;10:434. doi: 10.3390/diagnostics10060434.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics10060434</ArticleId><ArticleId IdType="pmc">PMC7345211</ArticleId><ArticleId IdType="pubmed">32604919</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnacle J.R., Houston H., Baltas I., Takata J., Kavallieros K., Vaughan N., Amin A.K., Aali S.A., Moore K., Milner P., et al. Diagnostic accuracy of the Abbott ID NOW SARS-CoV-2 rapid test for the triage of acute medical admissions. J. Hosp. Infect. 2022;123:92–99. doi: 10.1016/j.jhin.2022.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2022.02.010</ArticleId><ArticleId IdType="pmc">PMC8863956</ArticleId><ArticleId IdType="pubmed">35217130</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokes W., Venner A.A., Buss E., Tipples G., Berenger B.M. Prospective population-level validation of the Abbott ID NOW severe acute respiratory syndrome coronavirus 2 device implemented in multiple settings for testing asymptomatic and symptomatic individuals. Clin. Microbiol. Infect. 2023;29:247–252. doi: 10.1016/j.cmi.2022.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.08.025</ArticleId><ArticleId IdType="pmc">PMC9463071</ArticleId><ArticleId IdType="pubmed">36096431</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran A., Noble J., Deucher A., Miller S., Tang P.W., Wang R.C. Performance of Abbott ID-Now rapid nucleic amplification test for laboratory identification of COVID-19 in asymptomatic emergency department patients. J. Am. Coll. Emerg. Phys. Open. 2021;2:e12592. doi: 10.1002/emp2.12592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emp2.12592</ArticleId><ArticleId IdType="pmc">PMC8716572</ArticleId><ArticleId IdType="pubmed">35005704</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandarra S., Neto C., Gil F., Monteiro L., Brum L. ID NOW: A NAAT System Solution for the Rapid and Accurate Detection of SARS-CoV-2 with VTM Sampling. Med. Sci. Forum. 2023;22:13. doi: 10.3390/msf2023022013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/msf2023022013</ArticleId></ArticleIdList></Reference><Reference><Citation>Young S., Taylor S.N., Cammarata C.L., Varnado K.G., Roger-Dalbert C., Montano A., Griego-Fullbright C., Burgard C., Fernandez C., Eckert K., et al. Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test. J. Clin. Microbiol. 2020;59:e02338-20. doi: 10.1128/JCM.02338-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.02338-20</ArticleId><ArticleId IdType="pmc">PMC7771450</ArticleId><ArticleId IdType="pubmed">33023911</ArticleId></ArticleIdList></Reference><Reference><Citation>Farfour E., Yung T., Baudoin R., Vasse M. Evaluation of Four Fully Integrated Molecular Assays for the Detection of Respiratory Viruses during the Co-Circulation of SARS-CoV-2, Influenza and RSV. J. Clin. Med. 2022;11:3942. doi: 10.3390/jcm11143942.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11143942</ArticleId><ArticleId IdType="pmc">PMC9317686</ArticleId><ArticleId IdType="pubmed">35887705</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullah A., Sam I.-C., Ong Y.J., Theo C.H., Pukhari M.H., Chan Y.F. Comparative Evaluation of a Standard M10 Assay with Xpert Xpress for the Rapid Molecular Diagnosis of SARS-CoV-2, Influenza A/B Virus, and Respiratory Syncytial Virus. Diagnostics. 2023;13:3507. doi: 10.3390/diagnostics13233507.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13233507</ArticleId><ArticleId IdType="pmc">PMC10706428</ArticleId><ArticleId IdType="pubmed">38066748</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandarra S., Neto C., Monteiro L., Brum L. Performance of ID NOW Influenza A&amp;B 2. Med. Sci. Forum. 2023;22:28. doi: 10.3390/msf2023022028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/msf2023022028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kepka Z., Briksi A., Hubáček P., Zajac M., Dřevínek P. Characteristics of the ID-NOW™ test for the rapid detection of SARS-CoV-2. Epidemiol. Mikrobiol. Imunol. 2023;72:3–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">37185021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitamura K., Yamazaki M., Ichikawa M., Yasumi Y., Shiozaki K., Tokushima M., Abe T., Kawakami C. Clinical usefulness of a rapid molecular assay, ID NOW™ influenza A &amp; B 2, in adults. J. Infect. Chemother. 2021;27:450–454. doi: 10.1016/j.jiac.2020.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2020.10.009</ArticleId><ArticleId IdType="pubmed">33218876</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>